WallStreetZenWallStreetZen

NASDAQ: ORIC
Oric Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

Analyst price target for ORIC

Based on 3 analysts offering 12 month price targets for Oric Pharmaceuticals Inc.
Min Forecast
$14.00+48.46%
Avg Forecast
$19.00+101.48%
Max Forecast
$27.00+186.32%

Should I buy or sell ORIC stock?

Based on 3 analysts offering ratings for Oric Pharmaceuticals Inc.
Buy
Strong Buy
0 analysts 0%
Buy
3 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ORIC stock forecasts and price targets.

ORIC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-10-26
lockedlocked$00.00+00.00%2023-10-23
lockedlocked$00.00+00.00%2023-08-16

1 of 1

Forecast return on equity

Is ORIC forecast to generate an efficient return?
Company
N/A
Industry
-0.69%
Market
30.34%

Forecast return on assets

Is ORIC forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.29%

ORIC revenue forecast

What is ORIC's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$19.9M
Avg 2 year Forecast
$82.6M
Avg 3 year Forecast
$436.7M

ORIC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ORIC$9.43$19.00+101.48%Buy
ALEC$6.12$14.17+131.49%Buy
CRBU$5.81$23.00+295.87%Strong Buy
SPRY$5.32$13.00+144.36%Buy
ICVX$10.51$26.50+152.14%Strong Buy

Oric Pharmaceuticals Stock Forecast FAQ

Is Oric Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ORIC) stock is to Buy ORIC stock.

Out of 3 analysts, 0 (0%) are recommending ORIC as a Strong Buy, 3 (100%) are recommending ORIC as a Buy, 0 (0%) are recommending ORIC as a Hold, 0 (0%) are recommending ORIC as a Sell, and 0 (0%) are recommending ORIC as a Strong Sell.

If you're new to stock investing, here's how to buy Oric Pharmaceuticals stock.

What is ORIC's revenue growth forecast for 2026-2028?

(NASDAQ: ORIC) Oric Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.65%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.68%.

Oric Pharmaceuticals's revenue in 2023 is $0.On average, 2 Wall Street analysts forecast ORIC's revenue for 2026 to be $1,085,570,671, with the lowest ORIC revenue forecast at $86,191,038, and the highest ORIC revenue forecast at $2,084,950,304. On average, 2 Wall Street analysts forecast ORIC's revenue for 2027 to be $4,506,209,310, with the lowest ORIC revenue forecast at $20,729,490, and the highest ORIC revenue forecast at $8,991,689,131.

In 2028, ORIC is forecast to generate $23,822,002,830 in revenue, with the lowest revenue forecast at $23,822,002,830 and the highest revenue forecast at $23,822,002,830.

What is ORIC's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ORIC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.29%.

What is ORIC's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ORIC price target, the average ORIC price target is $19.00, with the highest ORIC stock price forecast at $27.00 and the lowest ORIC stock price forecast at $14.00.

On average, Wall Street analysts predict that Oric Pharmaceuticals's share price could reach $19.00 by Oct 26, 2024. The average Oric Pharmaceuticals stock price prediction forecasts a potential upside of 101.48% from the current ORIC share price of $9.43.

What is ORIC's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ORIC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.